
    
      Single arm, open label, prospective, observational study of gefitinib treatment for locally
      advanced (stage IIIB) or IV (metastatic) or relapsed NSCLC patients.

      Using DNA acquired from tumor tissue, sequencing and PNA-clamping for EGFR gene will be
      performed. The detection rates of EGFR mutation will be compared using paired samples.
    
  